CIK 0001660334 · Non-accelerated filer<br>Smaller reporting company
Verrica Pharmaceuticals Inc.
Sign in to watch- Ticker
- VRCA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 463137900
- Phone
- 484-453-3300
- Business address
- 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
- Open-market buys, last 90 days
- $109,690
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$109,690. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-11-22 | Rieger Jayson CEO and President | Purchase · Series A Warrants (right to buy) | +140,449 | 140,449 | ||
| 2024-11-22 | Rieger Jayson CEO and President | Purchase · Series B Warrants (right to buy) | +140,449 | 140,449 | ||
| 2024-11-22 | Stalfort John A III Director | Purchase | +1,123,595 | 1,823,800 | ||
| 2024-11-22 | Stalfort John A III Director | Purchase · Series A Warrants (right to buy) | +561,797 | 561,797 | ||
| 2024-11-22 | Stalfort John A III Director | Purchase · Series B Warrants (right to buy) | +561,797 | 561,797 | ||
| 2024-11-22 | Manning Paul B Director | Purchase | +18,426,966 | 26,278,094 | ||
| 2024-11-22 | Manning Paul B Director | Purchase | +4,494,382 | 5,976,101 | ||
| 2024-11-22 | Manning Paul B Director | Purchase · Series A Warrants (right to buy) | +9,213,483 | 9,213,483 | ||
| 2024-11-22 | Manning Paul B Director | Purchase · Series B Warrants (right to buy) | +9,213,483 | 9,213,483 | ||
| 2024-11-22 | Manning Paul B Director | Purchase · Series A Warrants (right to buy) | +2,247,191 | 2,247,191 | ||
| 2024-11-22 | Manning Paul B Director | Purchase · Series B Warrants (right to buy) | +2,247,191 | 2,247,191 | ||
| 2024-11-06 | Kirby John J. Interim CFO | Grant or award | +54,267 | 54,267 | ||
| 2024-11-06 | Rieger Jayson CEO and President | Grant or award · Employee Stock Option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2024-10-09 | Hayes Christopher G. CHIEF LEGAL OFFICER | Grant or award · Employee Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2024-09-19 | Manning Paul B Director | Gift | −2,675,611.25 | 0 | ||
| 2024-09-19 | Manning Paul B Director | Gift | +891,870.41 | 891,870.41 | ||
| 2024-09-19 | Manning Paul B Director | Gift | +891,870.42 | 891,870.42 | ||
| 2024-09-19 | Manning Paul B Director | Gift | +891,870.42 | 891,870.42 | ||
| 2024-08-27 | Hayes Christopher G. CHIEF LEGAL OFFICER | Sale | −9,530 | $2.46 | $23K | 105,773 |
| 2024-08-27 | Goldenberg Gary Chief Medical Officer | Sale | −3,601 | $2.46 | $9K | 94,261 |
Page 3 of 8 · 154 trades